Similar articles

• Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

  Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, Vanuytsel L, Bormans G, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G. Spaepen K, et al. J Clin Oncol. 2001 Jan 15;19(2):414-9. doi: 10.1200/JCO.2001.19.2.414. J Clin Oncol. 2001. PMID: 11208833
• Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.

  Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS. Delbeke D, et al. Oncologist. 2009;14 Suppl 2:30-40. doi: 10.1634/theoncologist.2009-S2-30. Oncologist. 2009. PMID: 19819922
• Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.

  Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G. Spaepen K, et al. Ann Oncol. 2002 Sep;13(9):1356-63. doi: 10.1093/annonc/mdf256. Ann Oncol. 2002. PMID: 12196360
• [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].

  Bourguet P; Groupe de Travail SOR. Bourguet P, et al. Bull Cancer. 2003 Feb;90 Spec No:S88-95. Bull Cancer. 2003. PMID: 12739340 Review. French. No abstract available.
• Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL.

  Jerusalem GH, Beguin YP. Jerusalem GH, et al. Clin Lymphoma. 2002 Jun;3(1):56-61. doi: 10.3816/clm.2002.n.012. Clin Lymphoma. 2002. PMID: 12141957 Review.